Profile supervisor at Norway’s biggest financial institution, DNB, anticipates a stock exchange upturn for both biotech firms Disc Medication and UCB following year.
发布者:BY Maria Outze,转转请注明出处:https://robotalks.cn/investor-predicts-success-for-two-biotech-companies-in-2026/